What Is the Contribution of Intraoperative Radiotherapy (IORT) in Tailoring Local Therapy in Primary or Recurrent Rectal Cancer?

  • Felipe A. Calvo


Combined modality therapy, preferably preoperative chemoradiation and radical surgery, is the standard of care for local treatment in patients with locally advanced rectal cancer. Local control is expected superior to 85% at 5 years. Intraoperative radiotherapy (IORT) is a high-quality radiation-boosting technique for dose-escalation purposes in limited anatomic regions evaluated and considered at risk at the time of surgical resection. In-field IORT recurrence rates are inferior to 5% in primary disease. The experience available using IORT as a component of treatment, both in primary and localized recurrent disease, is reviewed. Factors associated to topographic (in-field control/recurrence) pelvic results are discussed to potentially guide a tailored use of IORT according to local risk estimations.


Rectal Cancer Total Mesorectal Excision Local Recurrence Rate Advanced Rectal Cancer Preoperative Chemoradiation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kusters M, Marijnen CA, Van de Velde CJ et al (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36:470–476PubMedCrossRefGoogle Scholar
  2. 2.
    Kusters M, van de Velde CJ, Beets-Tan RG et al (2009) Patterns of local recurrence in rectal cancer: a single-center experience. Ann Surg Oncol 16:289–296PubMedCrossRefGoogle Scholar
  3. 3.
    Kusters M, Wallner C, Lange MM et al (2010) Origin of presacral local recurrence after rectal cancer treatment. Br J Surg 97:1582–1587PubMedCrossRefGoogle Scholar
  4. 4.
    Yu TK, Bhosale PR, Crane CH, Yyier RB et al (2008) Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 71:1175–1180PubMedCrossRefGoogle Scholar
  5. 5.
    Cantero-Muñoz P, Urién MA, Ruano-Ravina A (2011) Efficacy and safety of intraoperative radiotherapy in colorectal cancer: a systematic review. Cancer Lett 306:121–133PubMedCrossRefGoogle Scholar
  6. 6.
    Dubois JB, Bussieres E, Richaud P et al (2011) Intra-operative radiotherapy of rectal cancer: results of the French multi-institutional randomized study. Radiother Oncol 98:298–303PubMedCrossRefGoogle Scholar
  7. 7.
    Roeder F, Treiber M, Oertel S et al (2007) Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 67:1381PubMedCrossRefGoogle Scholar
  8. 8.
    Kusters M, Holman FA, Martijn H et al (2009) Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment. Radiother Oncol 92:221–225PubMedCrossRefGoogle Scholar
  9. 9.
    Díaz-Gonzalez JA, Calvo FA et al (2006) Prognostic factors for disease-free survival in patients with T3–4 or N + rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol Biol Phys 64:1122–1128PubMedCrossRefGoogle Scholar
  10. 10.
    Calvo F, Serrano J, Lozano MA et al (2011) Presacral evolutive events after post-neoadjuvant intraoperative presacral radiation boost for rectal cancer. Radiother Oncol 99(suppl 1):S18CrossRefGoogle Scholar
  11. 11.
    Haddock MG, Miller RC, Nelson H et al (2011) Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 79:143–150PubMedCrossRefGoogle Scholar
  12. 12.
    Kusters M, Dresen RC, Martin H et al (2009) Radicality of resection and survival after multimodality treatment is influenced by subsite of locally ­recurrent rectal cancer. Int J Radiat Oncol Biol Phys 75:1444–1449PubMedCrossRefGoogle Scholar
  13. 13.
    Kusters M, Valentini V, Calvo FA et al (2010) Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol 21:1279–1284PubMedCrossRefGoogle Scholar
  14. 14.
    Valentini V, Coco C, Rizzo G et al (2009) Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. Surgery 145:486–494PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Department of OncologyHospital General Universitario Gregorio MarañonMadridSpain

Personalised recommendations